Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PetVivo Holdings, Inc. (PETV)
Minneapolis, MN, US
PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications. Founded in 2009, PetVivo Holdings, Inc. maintains its corporate headquarters in Minneapolis, Minnesota.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Metric |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
115.6K
est: 120.1K (-3.8%)
|
917.2K
est: 941.6K (-2.6%)
|
968.7K
est: 975.3K (-0.7%)
|
1.13M
est: 8.90M (-87.3%)
|
8.90M
8.90M – 8.90M
+0.0% YoY
|
| EBITDA |
-4.99M
est: -120.1K (-4,055.1%)
|
-8.62M
est: -941.6K (-815.4%)
|
-10.49M
est: -975.3K (-976.1%)
|
-7.69M
est: -8.90M (+13.6%)
|
-8.90M
-8.90M – -8.90M
+0.0% YoY
|
| EBIT |
-5.06M
est: -120.1K (-4,109.4%)
|
-8.73M
est: -941.6K (-827.5%)
|
-10.62M
est: -975.3K (-989.1%)
|
-8.04M
est: -8.90M (+9.7%)
|
-8.90M
-8.90M – -8.90M
+0.0% YoY
|
| Net Income |
-4.94M
est: -11.48M (+56.9%)
|
-8.70M
est: -17.21M (+49.4%)
|
-10.96M
est: -13.17M (+16.8%)
|
-8.40M
est: -19.00M (+55.8%)
|
-19.00M
-19.00M – -19.00M
+0.0% YoY
|
| SGA |
4.50M
est: 5.12M (-12.2%)
|
8.43M
est: 40.15M (-79.0%)
|
10.09M
est: 41.58M (-75.7%)
|
7.47M
est: 127.43M (-94.1%)
|
127.43M
127.43M – 127.43M
+0.0% YoY
|
| EPS |
-0.56
est: -0.56 (+0.0%)
|
-0.85
est: -0.84 (-1.2%)
|
-0.78
est: -0.64 (-21.3%)
|
-0.41
est: -0.63 (+34.9%)
|
-0.63
-0.63 – -0.63
+0.0% YoY
|
Executive team
Executive team data is not available for this company yet.
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PETV
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
